Skip to content
Insider tapeFilings through Fri, Oct 16
Watchlist

Nadim Ahmed

CEO, President at Cullinan Therapeutics, Inc. (CGEM)

Purchase track record

Not enough history. Based on 0 purchases with a full 90 days of price history.

—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $518K

Reported trades

Filed Stock Type Shares Price Value Since
Feb 25SEC CGEMCullinan Therapeutics, Inc. Sell 13,515390,803 held (−3%) $14.47 $196K -10.6%
Feb 23SEC CGEMCullinan Therapeutics, Inc. Sell 16,381404,318 held (−4%) $13.62 $223K -5.1%
Dec 29SEC CGEMCullinan Therapeutics, Inc. Sell 9,922420,699 held (−2%) $10.01 $99K +29.2%